Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

PACB

Pacific Biosciences of California Inc

Jan 14 • 04:00PM ET

2.36

+0.23 10.80 %

Healthcare • Medical Devices • USA • NASD

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.18	Insider Own	10.29%	Shs Outstand	301.85M	Perf Week	10.80%
Market Cap	712.50M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-0.09%	Shs Float	270.83M	Perf Month	11.32%
Enterprise Value	1.11B	PEG	-	EPS next Q	-0.14	Inst Own	52.58%	Short Float	12.56%	Perf Quarter	48.43%
Income	-502.43M	P/S	4.61	EPS this Y	-64.82%	Inst Trans	-3.55%	Short Ratio	3.80	Perf Half Y	58.39%
Sales	154.58M	P/B	19.74	EPS next Y	71.81%	ROA	-44.60%	Short Interest	34.00M	Perf YTD	26.20%
Book/sh	0.12	P/C	2.38	EPS next 5Y	25.39%	ROE	-205.41%	52W High	2.72 -13.39%	Perf Year	17.41%
Cash/sh	0.99	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-68.31%	52W Low	0.85 177.29%	Perf 3Y	-75.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-210.02%	Volatility	10.36% 7.58%	Perf 5Y	-92.82%
Dividend TTM	-	EV/Sales	7.20	EPS Y/Y TTM	-16.00%	Oper. Margin	-357.07%	ATR (14)	0.17	Perf 10Y	-80.54%
Dividend Ex-Date	-	Quick Ratio	5.40	Sales Y/Y TTM	-10.72%	Profit Margin	-325.02%	RSI (14)	63.61	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	6.24	EPS Q/Q	43.24%	SMA20	21.71%	Beta	2.27	Target Price	2.31
Payout	-	Debt/Eq	19.40	Sales Q/Q	-3.82%	SMA50	16.35%	Rel Volume	1.30	Prev Close	2.13
Employees	575	LT Debt/Eq	19.38	Earnings	Nov 05 AMC	SMA200	56.85%	Avg Volume	8.95M	Price	2.36
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.02% -4.14%	Trades		Volume	11,595,464	Change	10.80%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	Loading…
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	Loading…
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
06:30PM	Loading…
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PACB

Pacific Biosciences of California Inc

Upgrade your FINVIZ experience